In the open-label FIBROMET trial, metformin treatment was associated with reductions in bone marrow fibrosis and downregulation of key oncogenic signaling pathways in patients wit ...

Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...

Researchers at Emory University have identified distinct patterns of DNA methylation in Indigenous Andean highlanders that ...

CEO and co-founder Brian Sullivan outlined the company’s clinical programs, regulatory progress, and commercial launch preparations for gedatolisib during a fireside chat at TD Cowen’s 46th Annual ...

Cats have long been something of a medical mystery. Compared to dogs, our feline friends receive a fraction of the research ...

Erasca (NASDAQ:ERAS) executives outlined the company’s strategy to target RAS-driven cancers and previewed upcoming clinical ...

Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...

The name might sound like a Nordic god, but it is actually the molecular machinery that allows many different species to eat ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from topical JAK ruxolitinib. Extensive or rapidly spreading disease is more ...

“The best introduction to the lifelong pleasure and rewards of looking at pictures since Gombrich. An instant classic.” Stephen Fry If you (like most viewers) of Jan van Eyck’s “Arnolfini Portrait” ...

Experts examine MFN pricing, the Great Healthcare Plan, ACA subsidies, PBM reform, and CMS talks in 2026. Lindsay Bealor ...